RIGEL PHARM (NASDAQ:RIGL)
7.78
-0 (-0%)
| RIGEL PHARM (NASDAQ:RIGL) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $7.78 | 52 Week High | $14.75 | ||
| Open | $7.70 | 52 Week Low | $4.19 | ||
| Day High | $7.86 | P/E | N/A | ||
| Day Low | $7.64 | EPS | $-3.24 | ||
| Volume | 332,905 | ||||
| More RIGL Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| NVAX | 2 | CELG | 1 |
| ALEX | 1 | AXL | 1 |
| IMMU | 1 | AMGN | 1 |
| SOMX | 1 | WFR | 1 |
| CEPH | 1 | ALGN | 1 |
| BRCM | 1 | MSFT | 1 |
Entities who have mentioned RIGL
- Credit Suisse | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Citi | View Related Stories »
- RBC Capital | View Related Stories »
- Goldman Sachs | View Related Stories »
- Barclays | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Jefferies & Co | View Related Stories »
- Piper Jaffray | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Bankruptcy | View Related Stories »
- Barack Obama | View Related Stories »
- Boenning & Scattergood | View Related Stories »
- Robert W Baird | View Related Stories »
- Stock Buyback | View Related Stories »
- UBS | View Related Stories »
- JPMorgan | View Related Stories »
- Kohlberg Kravis Roberts | View Related Stories »
- Dividend | View Related Stories »
- After-Hours Movers | View Related Stories »
- Wilbur Ross | View Related Stories »
- Stanford | View Related Stories »
- Collins Stewart | View Related Stories »
View All Major News StreetInsider.com Major News for RIGL
- Rigel Pharmaceuticals (RIGL) Sinks After RA Drug Falls To Meet Trial Endponits
- Rigel Pharmaceuticals (RIGL) Tops Q1 View By 17c
- Rigel Pharma (RIGL) Reports Q4 Loss of $0.91, Beats by 6c
View All ReportsStreetInsider.com Reports on RIGL
- Rigel Pharma (RIGL) Prices 13M Shares at $7.25
- After-Hours Movers 9/16: ARKR Higher; CKR, RIGL, VVUS, ORCL, EK, DBRN Lower
- Rigel Pharma (RIGL) to Sell 6M Shares in Offering
- Rigel Pharma (RIGL) August volatility decreases to 87 after Phase 2b results
- Morning Movers 7/24: CIT, ACPW, ALGN, CYTR, SPWRA Higher; RIGL, RVBD, NTCT, SIMG, DECK Lower
View All Press ReleasesCompany Press Releases on RIGL
- Rigel Announces Third Quarter 2009 Financial Results
- Rigel Announces Presentations at Two Investor Conferences
- Rigel to Webcast Analyst Briefing on October 20, 2009
StreetInsider Reports on RIGL by Category
View All BlogsBlogs on RIGL
- Financing Activity for Biotech Deals Heats Up
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
- Rigel Pharma: The Importance of Knowing Your Stock
- 7 'Babies with Bathwater' and 20 'Dogs with Fleas' for the Week
- FDA Calendar Updates: Celgene, NeurogesX, Rigel
Comments on RIGL
No comments are currently available.
